期刊文献+

肾素抑制剂阿利吉仑治疗高血压的现状

下载PDF
导出
摘要 目的综述肾素抑制剂阿利吉仑抗高血压药的现状。方法参阅相关文献,从一般介绍、药理学、临床试验、临床评价、不良反应和注意事项等对阿利吉仑治疗高血压的现状进行综述。结果与结论阿利吉仑对轻中度高血压有明显的疗效,可与其他抗高血压药联用;对其不良反应及学术观点的不同意见应予关注。
作者 叶立
出处 《中国药学杂志》 CAS CSCD 北大核心 2008年第21期1604-1607,共4页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献17

  • 1李华,郭冀珍.阿利吉仑——一种新型肾素抑制剂[J].中国新药与临床杂志,2006,25(3):216-219. 被引量:5
  • 2ZHANGAL DUXL.Novel antihypertensive drug:aliskiren .中国约学杂志,2008,43(3):237-238.
  • 3GRADMAN A H,KAD B. Renin inhibition in hypertension[J]. Am Coll Cardiol,2008,51 (5) :519-528.
  • 4Novartis Pharmaceuticals Corporation : Tekturna( aliskiren ) [ R ]. NDA21-985, February ,2007 ( T2007-05 ) ( T2007-06 ).
  • 5GRADMAN A, KOLLOCH R E, MYERS M,et al. Aliskiren in combination with hydrochlorothiazide is effective and well tolerated during long-termtreatment of hypertension [ J ]. J Clin Hypertens,2007,9 ( 5 suppl A ) : 160.
  • 6KUSHURO T,ITAKURA H, ABO Y,et al. Long-term safety and efficacy of aliskiren, an oral direct renin inhibitor,in Japanese patients with hypertension [ J]. J Clin ttypertens,2007,9 (5 Suppl A) :169.
  • 7OH B H, MITCHELL J,HERREON J R, et al. Aliskiren,an oral renin inhibitor, provides dose-dependent efficacy and sustained 24 h blood pressure control in patients. With hypertension [ J ]. J Am Coll Cardiol, 2007,49 ( 11 ) : 1157-1163.
  • 8VAIDYANATHAN S,REYNOLDS C,YEH C M, et al, Pharmacokinetics,Safety,and Tolerability of the novel oral direct rennin inhibitor aliskiren in olderly healthy subjects[ J]. J Clin Pharmacol ,2007,47 (4) :453-460.
  • 9ZHAO C,VAIDYANATHAN S, YEH C M,et al. Aliskiren exhibits similar pbarmacokineties in healthy volunteers and patients with type 2 diabetes mellitus [ J ]. Clin Pharmacokinet, 2006,45 (11) :1125-1134.
  • 10URESIN Y,TAYLOR A,KILO C,et al. Aliskiren,a novel rennin inhibitor, has greater BPlowering than ramipril and additional BPlowering when combined with ramipril in patients with diabetes and hypertension [J]. J Hypertens,2006,24 ( Suppl 4 ) : 82.

二级参考文献11

  • 1DZAU V.The cardiovascular continuum and renin-angiotensin-aldosterone system blockade[J].J Hypertens Suppl,2005,23 (1):S9-S17.
  • 2WOOD JM,MAIBAUM J,RAHUEL J,et al.Structure-based design of aliskiren,a novel orally effective renin inhibitor[J].Biochem Biophys Res Commun,2003,308(4):698-705.
  • 3SICA DA.Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy:its role in clinical practice[J].J Clin Hypertens,2003,5(6):414-420.
  • 4HOLLENBERG NK,FISHER NDL,PRICE DA.Pathways for angiotensin Ⅱ generation in intact human tissue:evidence from comparative pharmacological interruption of the renin system[J].Hypertension,1998,32(3):387-392.
  • 5AZIZI M,MENARD J,BISSERY A,et al.Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin Ⅱ-renin feedback interruption[J].J Am Soc Nephrol,2004,15(12):3126-3133.
  • 6DIETERLE W,CORYNEN S,MANN J.Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects[J].Br J Clin Pharmacol,2004,58(4):433-436.
  • 7HOLLENBERG NK.Angiotensin Ⅱ suppression in humans by the orally active renin inhibitor aliskiren (SPP100).Comparison with enalapril[J].Curr Hypertens Rep,2002,4(4):269-270.
  • 8WOOD JM,SCHNELL CR,CUMIN F,et al.Aliskiren,a novel,orally effective renin inhibitor,lowers blood pressure in marmosets and spontaneously hypertensive rats[J].J Hypertens,2005,23(2):417-426.
  • 9STANTON A,JENSEN C,NUSSBERGER J,et al.Blood pressure lowering in essential hypertension with an oral renin inhibitor,aliskiren[J].Hypertension,2003,42(6):1137-1143.
  • 10PILZ B,SHAGDARSUREN E,WELLNER M,et al.Aliskiren,a human renin inhibitor,ameliorates cardiac and renal damage in double-transgenic rats[J].Hypertension,2005,46(3):569-576.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部